logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (v) Distribution of new inpatient clients by age group for each primary drug

Substance<1515-1920-2425-2930-3435-3940-4445+Mean ageAge known (base)Age not known
Hypnotics and sedatives0.
Volatile substances8.347.624.412.
Cannabis 2.331.730.417.
Other substances


 The countries supplying data are: 

 BG, CZ, DK, IE, GR, CY, HU, RO, SK, FI, SE, UK, TR 

 The number of treatment clients in each country is listed in [Table TDI-7]. 

 See also 'TDI-104- New inpatient age and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page


 2006 Reitox national reports - Table TDI inpatient treatment centres. 

Page last updated: Monday, 12 November 2007